Advertisement
Screener

ALPINE IMMUNE SCIENCES, INC. Form SC 13G: Beneficial ownership report (passive)

Add as a preferred source on Google

ALPINE IMMUNE SCIENCES, INC. Form SC 13G: Beneficial ownership report (passive)

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2024-11-14: Form SC 13G/A; Description Beneficial ownership report (passive); Document greatpoint-alpn093024a3.htm.
  • 2024-03-07: Form SC 13G/A; Description Beneficial ownership report (passive); Document us02083g1004_030624.txt.
  • 2024-02-14: Form SC 13G/A; Description SC 13G/A; Document d783272dsc13ga.htm.
  • 2024-02-14: Form SC 13G/A; Description Beneficial ownership report (passive); Document greatpoint-alpn123123a2.htm.
FiledFormPeriod of reportDescriptionDocument
2024-11-14SC 13G/ABeneficial ownership report (passive)greatpoint-alpn093024a3.htm
2024-03-07SC 13G/ABeneficial ownership report (passive)us02083g1004_030624.txt
2024-02-14SC 13G/ASC 13G/Ad783272dsc13ga.htm
2024-02-14SC 13G/ABeneficial ownership report (passive)greatpoint-alpn123123a2.htm
2024-02-14SC 13G/ASC 13G/Atm246065d2_sc13ga.htm
2024-02-14SC 13G/ASC 13G/Atm245955d2_sc13ga.htm
2024-02-14SC 13G/ABeneficial ownership report (passive)schedule13g.htm
2024-02-14SC 13G/AALPINE IMMUNE SCIENCES, INC.p24-0770sc13ga.htm
2024-02-02SC 13GBeneficial ownership report (passive)us02083g1004_020224.txt
2023-10-23SC 13GBeneficial ownership report (passive)schedule13g.htm
2023-02-14SC 13G/ABeneficial ownership report (passive)greatpoint-alpn123122a1.htm
2023-02-14SC 13G/ASC 13G/Atm236410d3_sc13ga.htm
2023-02-14SC 13G/ASC 13G/Atm236221d19_sc13ga.htm
2023-02-14SC 13G/AAMENDMENT NO. 3 TO THE SCHEDULE 13Gsc13ga307422alpn_02142023.htm
2023-02-14SC 13G/ABeneficial ownership report (passive)d9942406_13g-a.htm
2023-02-14SC 13G/AALPINE IMMUNE SCIENCES, INC.p23-0349sc13ga.htm
2023-02-13SC 13G/ASC 13G/Ad429470dsc13ga.htm
2022-10-03SC 13GSC 13Gtm2227142d_sc13g.htm
2022-10-03SC 13GSC 13Gtm2227277d1_sc13g.htm
2022-09-30SC 13GBeneficial ownership report (passive)greatpoint-alpn092122.htm
2022-04-22SC 13GALPINE IMMUNE SCIENCES, INC.p22-1327sc13g.htm
2022-02-14SC 13G/ASC 13G/Ad310245dsc13ga.htm
2022-02-14SC 13GSC 13Gtm226449d2_sc13g.htm
2022-02-14SC 13G/AAMENDMENT NO. 2 TO THE SCHEDULE 13Gsc13ga207422alpn_02142022.htm
2022-02-14SC 13G/ABeneficial ownership report (passive)d9178726_13g-a.htm
2021-02-16SC 13G/ABeneficial ownership report (passive)d8798841_13g-a.htm
2020-12-23SC 13GBeneficial ownership report (passive)d8708208_13-g.htm
2020-08-06SC 13GSC 13Gd23684dsc13g.htm
2020-02-14SC 13G/AAMENDMENT NO. 1 TO THE SCHEDULE 13Gsc13ga107422alp_02142020.htm
2019-01-28SC 13GTHE SCHEDULE 13Gsc13g07422alp_01282019.htm
2017-07-27SC 13G/AAMENDMENT 3 TO THE SCHEDULE 13Gsc13ga307422010_07272017.htm
2017-02-14SC 13G/AAMENDMENT NO. 2 TO THE SCHEDULE 13Gsc13ga207422niv_02142017.htm
2017-02-10SC 13G/ASEC SCHEDULE 13GSEC13G_Filing.htm
2017-02-09SC 13G/ASEC SCHEDULE 13GSEC13G_Filing.htm
2016-03-22SC 13G/AAMENDMENT NO. 1 TO THE SCHEDULE 13Gsc13ga107422niv_03222016.htm
2016-02-11SC 13G/ASEC SCHEDULE 13GSEC13G_Filing.htm
2016-02-05SC 13GSCHEDULE 13G FOR NIVALIS THERAPEUTICS, INC. BY THE ESTATE OF ARNOLD H. SNIDER, Is13g_020316-nivalis.htm
2015-12-21SC 13GSCHEDULE 13Gsc13g07422niv_12212015.htm
2015-07-10SC 13GSEC SCHEDULE 13GSEC13G_Filing.htm
Advertisement